Terms: = Prostate cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568
188 results:
1. Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer.
Zelba H; Rabsteyn A; Bartsch O; Kyzirakos C; Kayser S; Seibold M; Harter J; Latzer P; Hadaschik D; Battke F; Golf A; Rettig MB; Biskup S
Front Immunol; 2023; 14():1271449. PubMed ID: 37920460
[TBL] [Abstract] [Full Text] [Related]
2. A CXCR4 inhibitor (balixafortide) enhances docetaxel-mediated antitumor activity in a murine model of prostate cancer bone metastasis.
Robinson T; Escara-Wilke J; Dai J; Zimmermann J; Keller ET
Prostate; 2023 Sep; 83(13):1247-1254. PubMed ID: 37244751
[TBL] [Abstract] [Full Text] [Related]
3. Network Toxicology Prediction and Molecular Docking-based Strategy to Explore the Potential Toxicity Mechanism of Metformin Chlorination Byproducts in Drinking Water.
Zhang GH; Liu H; Liu MH; Liu YC; Wang JQ; Wang Y; Wang X; Xiang Z; Liu W
Comb Chem High Throughput Screen; 2024; 27(1):101-117. PubMed ID: 37170985
[TBL] [Abstract] [Full Text] [Related]
4. Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancer.
Karbach J; Kiselicki D; Brand K; Wahle C; Sinelnikov E; Gustavus D; Hoffmeister H; Prisack HB; Atmaca A; Jäger E
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36627144
[TBL] [Abstract] [Full Text] [Related]
5. Cytotoxicity of Human Hepatic Intrasinusoidal Gamma/Delta T Cells Depends on Phospho-antigen and NK Receptor Signaling.
Kang Y; Han M; Kim M; Hwang HJ; Ahn BC; Tak E; Song GW; Hwang S; Koh KN; Jung DH; Kim N
Anticancer Res; 2023 Jan; 43(1):63-73. PubMed ID: 36585162
[TBL] [Abstract] [Full Text] [Related]
6. Reducing farnesyl diphosphate synthase levels activates Vγ9Vδ2 T cells and improves tumor suppression in murine xenograft cancer models.
Liou ML; Lahusen T; Li H; Xiao L; Pauza CD
Front Immunol; 2022; 13():1012051. PubMed ID: 36275712
[TBL] [Abstract] [Full Text] [Related]
7. Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant prostate cancer.
Vaishampayan UN; Thakur A; Chen W; Deol A; Patel M; Dobson K; Dickow B; Schalk D; Schienschang A; Whitaker S; Polend A; Fontana JA; Heath EI; Lum LG
Clin Cancer Res; 2023 Jan; 29(1):122-133. PubMed ID: 36255393
[TBL] [Abstract] [Full Text] [Related]
8. Generation and Functional Characterization of PLAP CAR-T Cells against Cervical cancer Cells.
Yekehfallah V; Pahlavanneshan S; Sayadmanesh A; Momtahan Z; Ma B; Basiri M
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139135
[TBL] [Abstract] [Full Text] [Related]
9. Signaling new therapeutic opportunities: cytokines in prostate cancer.
Chandran E; Meininger L; Karzai F; Madan RA
Expert Opin Biol Ther; 2022 Oct; 22(10):1233-1243. PubMed ID: 35930001
[TBL] [Abstract] [Full Text] [Related]
10. Combining Radiation- with Immunotherapy in prostate cancer: Influence of Radiation on T Cells.
Lindner D; Arndt C; Loureiro LR; Feldmann A; Kegler A; Koristka S; Berndt N; Mitwasi N; Bergmann R; Frenz M; Bachmann MP
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887271
[TBL] [Abstract] [Full Text] [Related]
11. The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk prostate cancer: A Validation Study From NRG/RTOG 0521.
Hall WA; Karrison TG; Rosenthal SA; Amin MB; Gomella LG; Purdy JA; Sartor AO; Michalski JM; Garzotto MG; Bergom C; Jani AB; Lawton CAF; Simko JP; Moore JK; Gore EM; Lee WR; Nguyen PL; Danielson BL; Sandler HM; Feng FY
Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):266-274. PubMed ID: 35675855
[TBL] [Abstract] [Full Text] [Related]
12. Immunotherapy in Genitourinary Malignancy: Evolution in Revolution or Revolution in Evolution.
Lu K; Chiu KY; Cheng CL
Cancer Treat Res; 2022; 183():201-223. PubMed ID: 35551661
[TBL] [Abstract] [Full Text] [Related]
13. Development of cancer Immunotherapies.
DeLucia DC; Lee JK
Cancer Treat Res; 2022; 183():1-48. PubMed ID: 35551655
[TBL] [Abstract] [Full Text] [Related]
14. IL-6 and IL-8 cytokines are associated with elevated prostate-specific antigen levels among patients with adenocarcinoma of the prostate at the Uganda cancer Institute.
Katongole P; Sande OJ; Nabweyambo S; Joloba M; Kajumbula H; Kalungi S; Reynolds SJ; Ssebambulidde K; Atuheirwe M; Orem J; Niyonzima N
Future Oncol; 2022 Feb; 18(6):661-667. PubMed ID: 34881637
[No Abstract] [Full Text] [Related]
15. MicroRNA-181a restricts human γδ T cell differentiation by targeting Map3k2 and Notch2.
Gordino G; Costa-Pereira S; Corredeira P; Alves P; Costa L; Gomes AQ; Silva-Santos B; Ribot JC
EMBO Rep; 2022 Jan; 23(1):e52234. PubMed ID: 34821000
[TBL] [Abstract] [Full Text] [Related]
16. Active Ingredients from
Yeh TH; Lin JY
Curr Issues Mol Biol; 2021 Aug; 43(2):996-1018. PubMed ID: 34563040
[TBL] [Abstract] [Full Text] [Related]
17. Clinical and immunological allergy assessment in cancer patients.
Carneiro BGMC; Petroianu A; Machado JAN; Dos Anjos PMF; da Silva FR; Alberti LR; Resende V; Barrientos SC
Sci Rep; 2021 Sep; 11(1):18110. PubMed ID: 34518597
[TBL] [Abstract] [Full Text] [Related]
18. IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC).
Pachynski RK; Morishima C; Szmulewitz R; Harshman L; Appleman L; Monk P; Bitting RL; Kucuk O; Millard F; Seigne JD; Fling SP; Maecker HT; Duault C; Ramchurren N; Hess B; D'Amico L; Lacroix A; Kaiser JC; Morre M; Grégoire A; Cheever M; Yu EY; Fong L
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452927
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of Circulating Immune Biomarkers by Race in Men With Metastatic Castration-Resistant prostate cancer Treated With Sipuleucel-T.
Hawley JE; Pan S; Kandadi H; Chaimowitz MG; Sheikh N; Drake CG
J Natl Cancer Inst; 2022 Feb; 114(2):314-317. PubMed ID: 34302463
[TBL] [Abstract] [Full Text] [Related]
20. Computational analysis of TMPRSS2 expression in normal and SARS-CoV-2-infected human tissues.
Cao W; Feng Q; Wang X
Chem Biol Interact; 2021 Sep; 346():109583. PubMed ID: 34284028
[TBL] [Abstract] [Full Text] [Related]
[Next]
